These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30518112)

  • 1. Multi-Study Proteomic and Bioinformatic Identification of Molecular Overlap between Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA).
    Šoltić D; Bowerman M; Stock J; Shorrock HK; Gillingwater TH; Fuller HR
    Brain Sci; 2018 Dec; 8(12):. PubMed ID: 30518112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Performance of Patients with Adult 5q-Spinal Muscular Atrophy and with Amyotrophic Lateral Sclerosis.
    Osmanovic A; Wieselmann G; Mix L; Siegler HA; Kumpe M; Ranxha G; Wurster CD; Steinke A; Ludolph AC; Kopp B; Lulé D; Petri S; Schreiber-Katz O
    Brain Sci; 2020 Dec; 11(1):. PubMed ID: 33374658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
    Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
    BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology.
    Comley LH; Nijssen J; Frost-Nylen J; Hedlund E
    J Comp Neurol; 2016 May; 524(7):1424-42. PubMed ID: 26502195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis.
    Sundaramoorthy V; Walker AK; Tan V; Fifita JA; Mccann EP; Williams KL; Blair IP; Guillemin GJ; Farg MA; Atkin JD
    Hum Mol Genet; 2015 Jul; 24(13):3830-46. PubMed ID: 25859013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Actin Cytoskeleton in SMA and ALS: How Does It Contribute to Motoneuron Degeneration?
    Hensel N; Claus P
    Neuroscientist; 2018 Feb; 24(1):54-72. PubMed ID: 28459188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Golgi fragmentation in amyotrophic lateral sclerosis, an overview of possible triggers and consequences.
    Sundaramoorthy V; Sultana JM; Atkin JD
    Front Neurosci; 2015; 9():400. PubMed ID: 26578862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spinal pathology in spinal muscular atrophy in comparison with amyotrophic lateral sclerosis].
    Urbanits S; Budka H
    Wien Med Wochenschr; 1996; 146(9-10):199-200. PubMed ID: 9012211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.
    Tosolini AP; Sleigh JN
    Front Mol Neurosci; 2017; 10():405. PubMed ID: 29270111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling motor neuron disease in fruit flies: Lessons from spinal muscular atrophy.
    Aquilina B; Cauchi RJ
    J Neurosci Methods; 2018 Dec; 310():3-11. PubMed ID: 29649521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticomotoneuronal integrity and adaptation in spinal muscular atrophy.
    Farrar MA; Vucic S; Johnston HM; Kiernan MC
    Arch Neurol; 2012 Apr; 69(4):467-73. PubMed ID: 22491191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasciculation discharge frequency in amyotrophic lateral sclerosis and related disorders.
    de Carvalho M; Swash M
    Clin Neurophysiol; 2016 May; 127(5):2257-62. PubMed ID: 27072098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis between amyotrophic lateral sclerosis and spinal muscular atrophy by skin involvement.
    Ono S; Mannen T; Toyokura Y
    J Neurol Sci; 1989 Jul; 91(3):301-10. PubMed ID: 2769298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis.
    Parboosingh JS; Meininger V; McKenna-Yasek D; Brown RH; Rouleau GA
    Arch Neurol; 1999 Jun; 56(6):710-2. PubMed ID: 10369311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives.
    Lejman J; Panuciak K; Nowicka E; Mastalerczyk A; Wojciechowska K; Lejman M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking amyotrophic lateral sclerosis and spinal muscular atrophy through RNA-transcriptome homeostasis: a genomics perspective.
    Gama-Carvalho M; L Garcia-Vaquero M; R Pinto F; Besse F; Weis J; Voigt A; Schulz JB; De Las Rivas J
    J Neurochem; 2017 Apr; 141(1):12-30. PubMed ID: 28054357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary motor neuropathies and motor neuron diseases: which is which.
    Hanemann CO; Ludolph AC
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Dec; 3(4):186-9. PubMed ID: 12710507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis.
    Farg MA; Soo KY; Warraich ST; Sundaramoorthy V; Blair IP; Atkin JD
    Hum Mol Genet; 2013 Feb; 22(4):717-28. PubMed ID: 23172909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.
    Perera ND; Sheean RK; Crouch PJ; White AR; Horne MK; Turner BJ
    Hum Mol Genet; 2016 Sep; 25(18):4080-4093. PubMed ID: 27466204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.